Connection
Michel Chonchol to Cardiovascular Agents
This is a "connection" page, showing publications Michel Chonchol has written about Cardiovascular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.473 |
|
|
|
-
Kendrick J, Chonchol M. Cardiovascular disease in CKD in 2013: Reducing cardiovascular risk--light at the end of the tunnel. Nat Rev Nephrol. 2014 Feb; 10(2):71-2.
Score: 0.414
-
van Kuijk JP, Flu WJ, Galal W, Chonchol M, Goei D, Verhagen HJ, Bax JJ, Poldermans D. The influence of polyvascular disease on the obesity paradox in vascular surgery patients. J Vasc Surg. 2011 Feb; 53(2):399-406.
Score: 0.021
-
van Kuijk JP, Flu WJ, Welten GM, Hoeks SE, Chonchol M, Vidakovic R, Verhagen HJ, Bax JJ, Poldermans D. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J. 2010 Apr; 31(8):992-9.
Score: 0.020
-
Welten GM, Schouten O, Chonchol M, Hoeks SE, Bax JJ, Van Domburg RT, Poldermans D. Prognosis of patients with peripheral arterial disease. J Cardiovasc Surg (Torino). 2009 Feb; 50(1):109-21.
Score: 0.018